Search: id:"swepub:oai:DiVA.org:uu-123001" >
The stability of AQ...
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease
-
Wiig, E H (author)
-
- Annas, P (author)
- Karolinska Institutet
-
Basun, H (author)
-
show more...
-
- Andreasen, N (author)
- Karolinska Institutet
-
- Lannfelt, Lars (author)
- Uppsala universitet,Geriatrik
-
Zetterberg, H (author)
-
Blennow, K (author)
-
- Minthon, Lennart (author)
- Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups
-
show less...
-
(creator_code:org_t)
- Hindawi Limited, 2010
- 2010
- English.
-
In: Acta Neurologica Scandinavica. - : Hindawi Limited. - 0001-6314 .- 1600-0404. ; 121:3, s. 186-193
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- OBJECTIVES: To explore the longitudinal stability of measures of cognition during treatment with acetylcholinesterase inhibitors (AchEI) in patients with Alzheimer's disease (AD). MATERIALS AND METHODS: Cognitive status was measured in a cohort of 60 patients at 6 months after initiation of treatment with AchEI (baseline) and after an additional 6 months of treatment (endpoint). A Quick Test of Cognitive Speed (AQT), Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), and MMSE were administered concurrently. RESULTS: Correlations (rho) between age and AQT processing speed were non-significant, but were significant for ADAS-Cog and Mini Mental State Examination (MMSE). AQT and ADAS-Cog means did not differ significantly between baseline and endpoint. There was a small, significant reduction in MMSE point scores. Measures of stability (Spearman's rho) were moderate-to-high for all tests. Means for subgroups did not differ as a function of medication type. CONCLUSIONS: AQT processing speed, ADAS-Cog, and MMSE measures proved stable during the second 6 months of treatment with AChEI.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Keyword
- AQT
- processing speed
- ADAS-Cog
- MMSE
- Alzheimer's disease
- AchEI treatment
- longitudinal stability
- MEDICINE
- MEDICIN
- treatment
- AchEI
- Alzheimer's disease
- MMSE
- ADAS-Cog
- AQT
- processing speed
- longitudinal stability
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database